|
DNaseX |
Dnase1l1tm1Dkfz
MGI:4430191 | Dnase1l1
deoxyribonuclease 1-like 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: muscular/coordination deficit | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Heart, muscle analyzed. Gene regulation identified in both organs. Regulated genes in heart associated with oxygen transporter activity and nucleic acid binding; in muscle with oxireductase activity and protein metabolsm. | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: increased body weight | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
NADHo |
| Aifm2
apoptosis-inducing factor, mitochondrion-associated 2 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: not tested | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
NCAM |
Ncam1tm1Cgn
MGI:1857222 | Ncam1
neural cell adhesion molecule 1 | Behavioral Screen
Phenotype:
Additional phenotype
Phenotype
description: increased exploratory activity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition (males). | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related difference | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: brain analyzed. Only two regulated genes found | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: reduced body weight, hypotherm (after fasting) | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
DKK3 |
Dkk3tm1Cni
MGI:3621929 | Dkk3
dickkopf homolog 3 (Xenopus laevis) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: hyperactivity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Clinical chemistry: Subtle changes of unclear relevance. Hematology: Hypochromic, macrocytic erythrocytes, increased hematocrit | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: Increased ventilation | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: reduced body weight, | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
DLG3 |
Gnl3Gt(W062C05)Wrst
MGI:4123403 | Gnl3
Guanine nucleotide-binding protein-like 3 - or Nucleostemin | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: No differences detected. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
MAG |
Magtm1Mtg
MGI:2384092 | Mag
myelin associated glycoprotein | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition in males. Hearing loss. Cramping, when hung by tail. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: tremor, abnormal gait | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia (males) | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: disturbances in the central respiratory control, | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: brain analyzed, no regulation detected | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Miz1 |
Pias2Gt(pT1Betageo)1Ruiz
MGI:2678428 | Pias2
protein inhibitor of activated STAT 2 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered social and exploratory behavior, middle ear phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: abnormal posture | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting different cellular subsets | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: reduced ventilatory drive, | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: testis analyzed, no regulation detected | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Confirmed phenotype
Phenotype
description: (reduced testis weight confirmed) | Report |
|
DMBT1 |
Dmbt1tm1Janm
MGI:3771872 | Dmbt1
deleted in malignant brain tumors 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: Subtle changes males more caution | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
DEA3 |
Tmc1Bth
MGI:2177263 | Tmc1
transmembrane channel-like gene family 1 | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: increased caution (males), increased angular velocity (females) | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Confirmed phenotype
Phenotype
description: Deafness. Changes in body composition (females) | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Well-pronounced B cell phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: differences in breathing pattern might be related to the different activity behavior | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: increased body weight | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Dll1 |
Dll1tm1Gos
MGI:1861919 | Dll1
delta-like 1 (Drosophila) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: hyperactivity (females) | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: hyperactivity | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related difference | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Thymus, liver, spleen, brain analyzed. Differential gene expression in all organs.Regulated genes associated with transcription and transport and binding activites. Several genes are involved in developmental processes. | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: reduced body weight and body fat | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Trm1 |
1190005F20RikGt(W027A02)Wrst
MGI:3702935 | Trm1
tRNA methionine initiator 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered exploratory behaviour | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Bone mineral density and body weight reduced in females. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: abnormal motor coordination/ balance | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: elevated IgE levels | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: brain analyzed, no gene regulation detected | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Phenotype
description: tendency of increased immunoreactivity
| Report |
|
MCHR1 |
Mchr1tm1Blak
MGI:3603521 | Mchr1
melanin-concentrating hormone receptor 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: hyperactivity during daytime, specific impairment in aversive memory | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Confirmed phenotype
Phenotype
description: Changes in bone homeostasis and body composition. | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: brain analyzed, no gene regulation detected | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: high rasper activity, not hyperphagic | Pathology Screen
Phenotype:
Phenotype
description: Dermatitis apostematosa
| Report |
|
Eyl |
Pitx3eyl
MGI:4429408 | Pitx3
paired-like homeodomain transcription factor 3 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered emotional behavior | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition (females). | Neurological Screen
Phenotype:
Additional phenotype
Phenotype
description: reduced grip strength | Eye Screen
Phenotype:
Confirmed phenotype
Phenotype
description: Severe microphthalmia | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Differences in fat metabolism and liver and/or pancreas function. Indications of effects on muscle function. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: altered spontaneous breathing pattern with more frequent | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: Liver analyzed, no regulation detected | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: reduced body weight, hypotherm (after fasting) | Pathology Screen
Phenotype:
Additional phenotype
Phenotype
description: red. Expression of dopamine transporter 1 in the mirdbrain (confirm)
Microphthalmia (females), BW reduced, increased extramedullary hematopoiesis (males) | Report |
|
Ptdsr |
Jmjd6tm1.1Gbf
MGI:3606752 | Jmjd6
jumonji domain containing 6 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: reduced anxiety | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. Hints on kidney dysfunction. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Thymus, brain, liver, spleen, heart analyzed. Differential gene regulation in thymus only. Regulated genes associated with heme binding. | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: Microphthalmia (not significant) | Report |
|
Vimentin |
Vimtm2Cba
MGI:1931879 | Vim
vimentin | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: abnormal social behavior (males) | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Bone mineral content, body weight and fat mass reduced in females. | Neurological Screen
Phenotype:
Additional phenotype
Phenotype
description: reduced grip strength | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Uric acid and white blood cell count increased. Indications of changes in kidney function and/or electrolyte homeostasis. Glucose level reduced in females | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia (males), Hyperalgesia (females) | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: respiratory rate differences failed to be statistically significant., In view of the observed pulmonary infection interpretation of the results is hardly possible. | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Spleen analyzed. Regulated gene asscociated with immune response and apoptosis | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Phenotype
description: increased T-cells in the PALS, reduced GFAP expression in the cerebellum
| Report |
|
mPtpg |
Nipal3tm1Pebu
MGI:4360699 | Nipal3
NIPA-like domain containing 3 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered exploration | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance in males only. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: elevated IgE levels | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
New phenotype
Phenotype
description: elevated ventilation detected during rest and activity is primarily related to the higher tidal volume used by mutant males | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: Brain analyzed, no differential gene regulation | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Cin85 exon 2 |
Sh3kbp1tm1Ivdi
MGI:4818424 | Sh3kbp1
SH3-domain kinase binding protein 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: hyperactivity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Changes in body composition in females. | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: elevated IgE levels | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Brain analyzed. Regulated gene associated with distinc brain functions and neurological disorders | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Phenotype
description: absence of the corpus callosum,
mice on B6 genetic background, confirmed by secondary screening
| Report |
|
pk 10681 |
|
| Behavioral Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Only changes of unclear relevance, mostly limited to one sex. There seems to be an influence on erytropoiesis but without pathological effects. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Spleen, liver analyzed. Regulated gene in spleen accociated with immune response. No gene regulation in liver. | Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: reduced body weight, | Pathology Screen
Phenotype:
Phenotype
description: enlarged marginal zone in the spleen
| Report |
|
TP53 |
Trp53inp1tm1Acar
MGI:3700974 | Trp53inp1
transformation related protein 53 inducible nuclear protein 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered locomotion | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
New phenotype
Phenotype
description: intraretinal microflecks, disturbances in retinal lamination | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting the cellular subsets distribution in the periphery | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related differences (females) | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Spleen, thymus analyzed. Differntial regulation in thymus. Regulated genes associated with GTPase activity and protein metabolism. | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: hypotherm (after fasting) | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Arl4 |
Arl4atm1Asch
MGI:2181269 | Arl4a
ADP-ribosylation factor-like 4A | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered arousal | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Small changes in bone mineral density and body weight in males. | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
Subtle phenotype
Phenotype
description: Slightly increased axial eye lengths in males | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hyperalgesia | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Hypertension | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No animals provided for organ collection
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: reduced body weight, hypotherm (ad libitum) | Pathology Screen
Phenotype:
Confirmed phenotype
Phenotype
description: no phenotype | Report |
|
HST009 |
Slc12a1I299F
MGI:103150 | Slc12a1
solute carrier family 12, member 1 | Behavioral Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition. | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Additional phenotype
Phenotype
description: Impaired kidney function confirmed. Changes in electrolyte homeostasis,indications of changes in bone metabolism and increased pancreas activity, increased white blood cell count and mild erythropenic anemia. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Well-presented immunological phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hyperalgesia (females) | Cardiovascular Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related differences | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: Kidney analyzed, no gene regulation found | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: increased body weight | Pathology Screen
Phenotype:
Additional phenotype
Phenotype
description: bilateral hydronephrosis (confirmed)
ovarian cystic changes (additional) | Report |
|
FoxP2-h |
Foxp2tm1Woen
MGI:3851106 | Foxp2
forkhead box P2 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Hypoactivity, increased caution | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: hypoactivity | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: No differences detected. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: Brain analyzed, no differential gene regulation | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Glut8 |
| Slc2a8
solute carrier family 2, (facilitated glucose transporter), member 8 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: increased emotional reactivity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: reduced grip strength (males) | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Muscle, testis, liver analyzed. Regulated genes in muscle and liver are associated with functions in fatty acid and glucose metabolism. No gene regulation in testis. | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: energy balance | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
M76C04 |
Nkain4Gt(M076C04)Vmel
MGI:4413343 | Nkain4
Na+/K+ transporting ATPase interacting 4 | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance regarding locomotion and behaviour towards the board | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
New phenotype
Phenotype
description: nuclear or posteriorpolar opacity | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: Finding of unclear relevance. CD44 is also expressed on activated B cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
No phenotype
Phenotype
description: Brain analyzed, no differential gene regulation | Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Body temperature reduced | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Eps8 |
Eps8tm1Ppdf
MGI:3693626 | Eps8
epidermal growth factor receptor pathway substrate 8 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered exploratory pattern | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Deafness. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Hypoactivity | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Subtle changes of unclear relevance. Hyperkalemia, which might influence pulse rate.Indications of effects on energy metabolism. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: Expression of homing markers, possibly due to activation?? | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Bradycardia | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtitle Changes, body weight related differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: White fat, brown fat, liver analyzed. The significantly expressed genes are associated with functions in fatty acid metabolism, apoptosis and actin remodeling. | Energy Metabolism Screen
Phenotype:
Confirmed phenotype
Phenotype
description: impaired gastro-intestinal functions | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Cs7 |
|
| Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered emotional behavior | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Lean mass increased (females). | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: muscle force | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. Regulation of hematopoiesis might be affected. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: Finding of unclear relevance. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: slight differences between female groups, physiologically not relevant | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Subtle phenotype
Phenotype
description: spontaneus myocardium calcification 26% of the congenic mice (not significant) | Report |
|
Dll1 C3H |
Dll1tm1Gos
MGI:1861919 | Dll1
delta-like 1 (Drosophila) | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: mild alterations in horizontal activity/exploration | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition. | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Indication of an effect on energy metabolism and hematopoiesis. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: alterations in the memory T cell compartment. Normally, CD62L expression is high on naïve Tcells and central memory cells. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Hypotension (males), Bradycardia, | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body weight related differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Thymus, spleen, liver and brain analysed. Several of the significantly expressed genes in liver, brain and thymus are associated with apoptosis, regulation of cell cycle, tumorigenesis, em-bryogenesis, and different neu-ronal functions. | Energy Metabolism Screen
Phenotype:
Confirmed phenotype
Phenotype
description: Body mass reduced | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: (BW confirmed) | Report |
|
C3H vis |
Pde6b+
C3H.C-Pde6b+/H | Pde6b
phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered exploratory pattern | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: Changes in bone homeostasis and body composition (secondary effect due to clear differences in body parameters) | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
New phenotype
Phenotype
description: Increased axial length in C3H.Pde6b+, no b-G73wave response in C3H.Pde6b+ | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Reduced percentage of CD8+ T cells and höherer percentage of granulocytes,sex: Male: Reduced percentage of CD4+ T cells, Increased IgG2b plasma level (only males) | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: Hypoalgesia (females) | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: C3H.Pde6b+ mutant mice carry a functional BalbC allele of the gene of interest, while the control C3H/HeH mice represent a natural null allele of Pde6b. Among the commonly used lab strains we find that these C3H mice with retinal degeneration exhibit relatively high values for QT interval and QTc. | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Major phenotype unlikely, mainly body weight related differences. | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Brain, heart and eye selected. Differential gene expression in all ana-lyzed organs. Genes regulated in eye are associated with retina dis-eases, corneal wound healing and apoptosis or are expressed corneal epithelium and different retina layers. Several of the significantly ex-pressed genes in heart are involved in distinct heart failure (e.g. car-diac hypertrophy or cardiomyopathy). | Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: reduced body weight, | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Eya3 |
Eya3Gt(W096D02)Wrst
MGI:3834107 | Eya3
eyes absent 3 homolog (Drosophila) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: altered exploratory pattern | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Subtle phenotype
Phenotype
description: Bone mineral content, body length and body weight reduced in males. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: reduced grip strength | Eye Screen
Phenotype:
Subtle phenotype
Phenotype
description: Difference in normalised (for body length) axial eye length. | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Changes in conduction and voltage properties | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Decreased tidal volume | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: muscle, heart, brain analyzed. In muscle no differences in expression levels between
mutant and control mice have been detected. Several of the significantly
expressed genes in brain and heart are associated with protein synthesis,
synaptic vesicle exocytosis or they are expressed in different neuronal
cell types | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
TGFB1 |
| Tgfb1
transforming growth factor, beta 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Mild hyperactivity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: Potential Phenotype: a single mouse mutant with unusually high percentage of CD4+CD25+ co-expressing cells. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Phenotype
description: no phenotype
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Minor differences only | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Liver, kidney analysed. Regulated genes in kidney associated with proteolysis, oncogenesis & cholesterol metabolism. In liver: roles in cation transport, cell structure and cell motility. | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
GSK3 beta |
| Gsk3b
glycogen synthase kinase 3 beta | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Reduced velocities, eventually increased anxiety | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: reduced grip strength | Eye Screen
Phenotype:
Subtle phenotype
Phenotype
description: Slightly reduced axial eye lengths | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Changes in energy metabolism related parameters indicate effects on energy balance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: sex: Male: only male: increased percentage of B cells, reduced percentage of Granulocytes, slightly increased percentage of gdT cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: Male: mutant mice have slightly decreased testosterone concentrations | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Changes in conduction properties, hypotension, bradycardia | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Body mass related differences, physiologically not relevant | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: brain, pancreas and muscle analysed. Regulated genes in brain and muscle asscociated with tumorigenesis, neuronal functions and muscle differentiation. | Energy Metabolism Screen
Phenotype:
Additional phenotype
Phenotype
description: Hypermetabolic | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: vacuolization of different severity of some brain structures (particularly
substancia nigra, dorsal fornix, cingulum, truncus corporis callosi) could be
detected. Possible demyelinization disease | Report |
|
FoxP2-KO |
Foxp2tm2.2Woen
MGI:3851108 | Foxp2
forkhead box P2 | Behavioral Screen
Phenotype:
Additional phenotype
Phenotype
description: Confirmed hypoactivity, reduced neophobia | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
Confirmed phenotype
Phenotype
description: abnormal motor coordination/ balance also in heterozygous animals | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: sex: Male: increased percentage CD62L-expressing CD8+ T cells (only males ),sex: Female: increased percentage of T cells (only females). | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Phenotype
description: no phenotype
| Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: No differences of phjysiological relevance | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Hypermetabolic | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
C1orf37 |
Tg(TMEM183B)1Pbo
MGI:4819559 | Tmem183a
transmembrane protein 183A | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: mild hyperactivity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: Minor changes | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
T181 |
Gpertm1Dgen
MGI:4355679 | Gper
G protein-coupled estrogen receptor 1 | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: slightly increased anxiety | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Reduced expression in T cells, with reduced L-selectin expression. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Hypercontractility of the left ventricle | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: brain, kidney, thymus analyzed. Several of the significantly regulated genes in thymus are associated with tumorigenesis and immune response. No gene regulation in brain and kidney | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
GSK3 alpha |
| Gsk3a
glycogen synthase kinase 3 alpha | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: increased anxiety | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition in males | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
New phenotype
Phenotype
description: sex: Male: Increased axial eye length in males | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Results indicate effects on hematopoiesis resulting in macrocytosis, and changes in energy metabolism. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: sex: Female: Differences in percentage between T and B cells: (only females). | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: Female: mutant mice have decreased DHEA concentrations | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Hypotension, Bradycardia | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: n/a
| Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Brain, muscle analyzed.Regulated gene in muscle are associated with blood circulation and gas exchange and protein phosphorylation. No gene regulation in brain | Energy Metabolism Screen
Phenotype:
Additional phenotype
Phenotype
description: Body mass reduced, strong response to fasting | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Dll1-C413Y |
Dll1C413Y
| Dll1
delta-like 1 (Drosophila) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Hyperactivity sex: female: enhanced prepulse inhibition | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Hyperactivity | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Plasma lipid and urea values suggest changes in energy metabolism. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: sex: Male: In males we foand a reduced frequency of ICAM-1 expresssing cells and slightly higher levels of IgG2a and IgG2b | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Hypertension | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: sex: Female: Only female mice showed slight differences, physiologically not relevant | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Liver, spleen, brain and thymus analysed. Gene differentially expressed in spleen associated with cell proliferation, signaling and embryogenesis. No gene regulation found in liver, thymus, and brain. | Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Body mass reduced, hypermetabolic | Pathology Screen
Phenotype:
Phenotype
description: no phenotype
| Report |
|
HST012 |
UmodA227T
MGI:102674 | Umod
Uromodulin | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition. | Neurological Screen
Phenotype:
Not tested
Phenotype
description: not tested due to limited mouse number
| Eye Screen
Phenotype:
Not tested
Phenotype
description: not tested due to limited mouse number
| Clinical Chemical Screen
Phenotype:
Additional phenotype
Phenotype
description: Impaired kidney function confirmed , additional effects on energy metabolism, bone metabolism and blood cell count. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: sex: (females) L-selectin (CD62L) expression on Tcells, especially CD8+, is higher (heterozygous and homozygous), sex: Male: Ly6C expression on CD8 Tcells is reduced (males). | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
New phenotype
Phenotype
description: sex: Female: Hyperalgesia (females) | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Increased Plasma-ANP levels | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Kidney analysed. Significantly regulated genes in kidney are annotated with hemolytic anemia, glomerulosclerosis, hypertension, diabetes and tumorigenesis | Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
Additional phenotype
Phenotype
description: sex: Female: (females) Ovarian cysts in females, (reduced body weight) | Report |
|
EMP3 |
| Emp3
epithelial membrane protein 3 | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: subtle alterations of unclear relevance | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: No differences detected. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: The frequency of T cells, among other subsets, differed betweent mutants and wildtypes. However, we did not see a consistent phenotype comparing two different batches of mice. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
New phenotype
Phenotype
description: Spleen and thymus analysed. Significantly regulated genes in spleen were annotated with cell communication, apoptosis, transcription regulation or calcium mediated signaling. These data indicate molecular changes of cellular processes in which the mutated gene EMP3 might also be involved. No gene regulation found in thymus | Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
Irf1 |
| Irf1
interferon regulatory factor 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Results indicate effects on fat and glucose metabolism, moderate macrocytosis and reduced ALP and amylase activity in mutants. | Immunology Screen
Phenotype:
Confirmed phenotype
Phenotype
description: Described phenotype of a low freq. of CD8+ Tcells and of inverse trend in CD4+ Tcells was confirmed. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: Male: mutant mice have slightly increased DHEA concentrations | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain | Report |
|
Setdb1 |
| Setdb1
SET domain, bifurcated 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Prepulse inhibition deficit, sex: Female: hyperactivity (females) sighted C3H | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: No significant differences detected. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: Mutant mice have low levels of IgE | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: sex: Male: Tachycardia, increased heart weight in males | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: slight differences of minor physiological relevance | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain and liver | Report |
|
Aldh2 |
| Aldh2
aldehyde dehydrogenase 2, mitochondrial | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Sex-specific alterations in activity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Decreased triglyceride levels and mild macrocytosis in mutant animals. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: Male: mutant mice have slightly decreased DHEA concentrations | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Tachycardia, increased heart weight | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Pathology Screen
Phenotype:
New phenotype
Phenotype
description: beta-Gal activity: in brain, heart, liver, lung, spleen, kidney, thyroid, skin, testes, ovaries, Histology: 2 of 4 mutant males have mild testicular tubular degeneration | Report |
|
EUCJ0019_C12 |
| Pml
promyelocytic leukemia | Behavioral Screen
Phenotype:
Subtle phenotype
Phenotype
description: subtle changes of unclear relevance | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Not tested
Phenotype
description: no phenotype
| Neurological Screen
Phenotype:
Phenotype
description: Hyperactivity
| Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Differences compared to wildtype controls were foand concerning the freq. of CD19+/CD5+ cells, and the proportions of T cell subsets. Especially, T cells from Plm mutant mice showed a high expression of CD62L+ (CD4+ and CD8+), a high expression of CD44 ( | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: not tested | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: no phenotype
| Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
EPD0105_5_E01 |
| Dusp4
dual specificity phosphatase 4 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: sex: Female: Reduced anxiety (females) | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Phenotype
description: no phenotype
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Bradycardia | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain, testes and ovary | Report |
|
EUC FP00100C08 |
| Nos2
nitric oxide synthase 2, inducible | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Prepulse inhibition deficit only in females | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Many mild differences of unclear relevance. Fat metabolism, kidney function and liver function and integrity might be affected. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Nos-2 mutant mice showed a slightly higher freq. of T cells and NK cells and a lower freq. of Bcells. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: Male: mutant mice have slightly increased DHEA concentrations | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no genotype-related differences | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: Hypermetabolism | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
EPD0028_5_G01 |
| Hdac1
Histone deacetylase 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: More excitation/Alertness (Tail elevation) | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Lower levels of IgM | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Bradycardia | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: differences ofphysiological minor relevance, specific TV and specific MV are comparable | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Phenotype
description: Hypermetabolism, fat mass reduced
| Pathology Screen
Phenotype:
No phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain, testes and ovary | Report |
|
EPD0051_2_D09 |
| Plxnb2
plexin B2 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Increased prepulse inhibition only in females | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: abnormal motor coordination/ balance | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle changes of unclear relevance. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: sex: Female: Higher freq. of B cells, lower freq. of T cells and NK cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
Subtle phenotype
Phenotype
description: Subtle phenotype | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain and lung | Report |
|
EUCJ0004_F10 |
| Nfya
nuclear transcription factor-Y alpha | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: smaller head
decreased body length, body weight, and fat mass in males. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Hind limb shaking upon tail suspension
Reduced grip strength | Eye Screen
Phenotype:
Subtle phenotype
Phenotype
description: Significant difference of absolute axial eye lengths (both sexes) and normalized (for body length) eye sizes (males). Differences are of unclear relevance. | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: small effects on potassium, phosphorus, creatinine, glucose and iron >> accidental or possibly secondary to changes in muscle metabolism?? | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Sex-dependent phenotype: Only in female mutants higher freq. of T cells and inverse trend in B cells and granulocytes. T cells show a higher expression of CD62L and a lower expression of Ly6C (CD8+), corresponding to a more naive phenotype. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Decreased pulse rate, mainly in males
Slightly decreased HW/TBL in combination with decreased BW and increased TBL (not significant trend to decreased HW). Probably secondary to BW differences | Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Body mass and fat mass reduced in males | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
EPD0059_3_A06 |
| Acot13 (alt Them2)
acyl-CoA thioesterase 13 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Total center time increased in the male mutants | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: decreased body weight in males. | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fasted mice: Tendency towards increased cholesterol values.
IpGTT: only females: Decreased fasted glucose level, decreased glucose clearance | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: In female mutants we found a lower proportion of CD44/Ly6C co-expressing CD8+ T cells, and a lower freq. of CD11b expressing NK cells compared to wt controls.
High IgG1 in male mutants | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: High IgE in male mutants | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: VO2 reduced due to reduced body mass
Body mass and fat mass decreased in males | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain | Report |
|
EPD0156_1_B01 |
Entpd1tm1a(EUCOMM)Wtsi
| Entpd1
ectonucleoside triphosphate diphosphohydrolase 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: decreased BMD in males (probably secondary effect). | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Significantly improved rotarod performance | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Mild macrocytosis, decreased platelet count increased platelet volume
Improved glucose tolerance | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Slightly reduced freq. of NK cells, but a higher proportion of CD11b expressing NK cells.
Sex-dependent differences in the expression of CD44 and CD62L on T cells:
Males: lower prop. of Cd62L expr. CD4+ Tcells, higher freq. of Ly6C expr. CD8+ Tcells.
Females: Higher freq. of CD44++ CD8+ T cells, furthermore higher ratio of CD4:CD8 | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
New phenotype
Phenotype
description: Decreased corticosterone levels in females | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Body mass and fat decreased | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in uterus and pancreas | Report |
|
EPD0060_1_B12 |
Hgstm1a(EUCOMM)Wtsi
| Hgs
HGF-regulated tyrosine kinase substrate | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: Female mutants are moving around more | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: Fed: Tendency towards increased glucose and iron level, tendency towards macrocytosis | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: A trend of a reduced freq. of T cells in mutants | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Body mass and fat mass increased in males | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain and liver | Report |
|
EPD0087_1_G04 |
Fermt2tm1a(EUCOMM)Wtsi
| Fermt2
fermitin family homolog 2 (Drosophila) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Female mutants show a small significant increase in centre time, only during the last 5 minutes of the test | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Clinical chemistry fasted mice: Moderately decreased cholesterol and HDL-cholesterol concentrations;
Fed mice: Potassium, iron and Amylase activity (trend) decreased ALP activity increased in males, cholesterol decreased in mutants;
Hematology: WBC, MCV (WT low?), (HCT) increased in males, same tendency in females for WBC, MCHC decreased in both sexes
>> findings of unclear relevance
IpGTT: Males loose more weight due to fasting than expected. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: Lower frequency in T cells and higher frequency in B cells in both, females and males. Furthermore, higher frequency of CD44-expressing T cells in males. | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: MiniSpec NMR: decreased body mass, fat and lean content but no shift in body composition | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Report |
|
EPD0155_1_D04 |
Myl4tm1a(EUCOMM)Wtsi
| Myl4
myosin, light polypeptide 4 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Increased locomotor activity in both the male and female mutants; decreased rearing in the male mutants and increased rearing in the female mutants;
PPI: Decreased PPI in male and female mutants at the 69dB intensity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: hyperactivity | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Clinical chemistry: Fasted mice: Mainly/only males Cholesterol (HDL and non-HDL) decreased, NEFA increased;
Fed mice: ALP and iron increased, sodium and phosphate (trend) decreased; only males: Amylase and glucose decreased;
Hematology: RBC, (HCT), HGB (f) increased, MCV and MCH (m) MCHC (m) decreased: Polycytemia | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Ig: higher levels of IgA (both sexes), and IgG1 and IgM (only males) | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in atria (heart ) | Report |
|
EPD0183_3_F08 |
Dlec1tm1a(EUCOMM)Wtsi
| Dlec1
deleted in lung and esophageal cancer 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: less urination; Rotarod: more falling | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Increased body weight, reduced body fat, increased lean mass | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in bronchi and ependym | Report |
|
MTA3 |
| Mta3
metastasis associated 3 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Significantly decreased rearing behaviour in both male and female mutants;
PPI: Decreased PPI in female mutants at 67 and 73 dB and globally | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: Hypoactivity, less vocalization in females | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Chlinical chemistry: Fed mice: Increased ALP activity, increased liver enzyme activities only in males; slight increase of iron level and decrease of creatinine concentration that might be accidental.
Fasted mice: No clear effects, slightly decreased cholesterol in females.
Hematology: Slightly decreased PLT, tendency towards increased MCV and MCHC
IpGTT: Decreased fasted glucose level (mainly in females), improved glucose clearance (mainly in males) | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: In both sexes, mutant mice had a higher CD4/CD8 ratio then controls. Only in female mice, this was due to a significantly higher freq. of CD8 T cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
New phenotype
Phenotype
description: corticosterone level increased in male mutants | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Lung Function Screen
Phenotype:
Subtle phenotype
Phenotype
description: higher tidal volumes in mutant males at rest; possible alteration in the regulation of breathing; | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in bladder, brain, colon, heart, lung, skin, spleen, stomach, testis, thyroid, thymus | Report |
|
EPD0102_1_D06 |
Arvcftm1a(EUCOMM)Wtsi
| Arvcf
armadillo repeat gene deleted in velo-cardio-facial syndrome | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Increased locomotor activity and decreased rearing activity by the mutants; Significantly decreased PPI in the mutants at 67dB intensity and tendency (p=0.056) to decreased PPI in the mutant mice globally | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: Hopping gait, tendency to hyperactivity; Rotarod: Reduced latencies | Eye Screen
Phenotype:
New phenotype
Phenotype
description: Funduscopy: White fundus flecks in some cases (controls and mutants); Slit lamp biomicroscopy: Lens nuclear and zonular opacity in all mutants | Clinical Chemical Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: Frequency of B cells increased, changes in T cell subsets (CD62L, CD44) | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Decreased pulse rate mainly in males | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: No clear difference in body mass or body composition | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in Kidney, Oviduct, Brain | Report |
|
HEPD0073_3_C11 |
Wbscr16tm1a(EUCOMM)Hmgu
| Wbscr16
Williams-Beuren syndrome chromosome region 16 homolog (human) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Decreased rearing in the male mutants and increased rearing in the female mutants;
Decreased PPI in the male and female mutants | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Rotarod: Mutant mice fall more often from the rod (79% vs. 56%) | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
Subtle phenotype
Phenotype
description: no phenotype | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Slightly lower proportion of CD25 expressing CD4 T cells, and lower proportion of CD11b expressing NK cells in mutants | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
Subtle phenotype
Phenotype
description: decreased testosterone levels in male mutants | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Phenotype
description: pending
| Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain | Report |
|
Asxl |
Asxl1tm1a(EUCOMM)Wtsi
| Asxl1
additional sex combs like 1 (Drosophila) | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Small increase in locomotor activity during last 5 minutes; PPI: Small increase in PPI in the mutants at the 81dB intensity | Dysmorphology, Bone and Cartilage Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: Less urination, more vocalization | Eye Screen
Phenotype:
New phenotype
Phenotype
description: Absolute and normalized axial eye lengths are significantly decreased in the mutants compared to C57BL/6NTac baseline data; Microphthalmia in two males and two females. Corneal opacity in two males and four females. Iris anomaly in one male and three females; A tendency towards reduced vision in males and females. This might be a secondary effect of the slit lamp phenotypes; | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fasted mice: non-HDL-Cholesterol, Triglycerides, NEFA and Glycerol low; Non-fasted mice: Low ALT and AST activities (accidental?) mild increase in ALP activity and iron levels. | Immunology Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Decreased pressure parameters and pulse rate mainly in females; Increased absolute and normalized heart weight | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: no organs collected
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Slightly reduced body fat, and increased lean mass | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in Stomach, Kidney, Brain, Heart, Colon, small intestine, ovary, oviduct, uterus | Report |
|
Cidec |
Cidectm1a(EUCOMM)Wtsi
MGI:4433521 | Cidec
cell death-inducing DFFA-like effector c | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Decreased rearing in the male mutants with the opposite effect in the female mutants; tendency to increased centre time by the male mutants with the opposite effect in the female mutants | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: DXA: decreased BMD, BMC and bone content in males; decreased body weight, fat mass and fat content; increased lean mass and lean content in males. | Neurological Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fed mice: Slightly increased Calcium, TP and Albumin, Cholesterol and amylase activity (liver metabolism); IpGTT: High fasting-induced BW loss, high basal glucose level in fasted mice? | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: Lower frequency of CD8 T cells, higher frequency of B cells. Sex-specific phenotype: in males lower frequency of NK and NK/CD11b+ cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
New phenotype
Phenotype
description: Increased absolute (ANOVA) and normalized heart weight | Lung Function Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: no organs collected
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Clearly reduced body fat, increased lean mass, massive shift in body composition | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in adipose tissue | Report |
|
Impad1 |
Impad1tm1a(KOMP)Wtsi
MGI:4363750 | Impad1
inositol monophosphatase domain containing 1 | Behavioral Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: DXA: increased body weight and fat mass in males. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: SHIRPA: Less tail elevation, Rotarod: Subtle improvement | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fasted mice: Females cholesterol decreased (total, HDL and less non-HDL), tendencies: decreased NEFA and increased glucose; Fed mice: Trends in females: Phosphate, TP, cholesterol, ASAT increased; Hematology: MPV increased in females; IpGTT: Females loose less weight than expected (trend); basal glucose level in fasted mice increased in females and decreased in males (different from fasted blood). | Immunology Screen
Phenotype:
Subtle phenotype
Phenotype
description: Slightly higher levels of IgM in mutants, especially males | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Phenotype
description: pending
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: increased body mass especially in male mutants, reduced mean oxygen consumption | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in brain, olfactory bulb, organum subcommissurale, fornix | Report |
|
Hells |
| Hells
helicase, lymphoid specific | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Increased distance travelled by the male mutants and tendency to decreased centre time by the female mutants; Decreased PPI in the male mutants at the 81dB intensity
| Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: DXA: decreased body length and body weight in males. | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: abnormal gait, improved rotarod performance by female mutants | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fasted mice: Low cholesterol, non-HDL-Cholesterol and triglyceride levels; IpGTT: Fasting induced weight loss high, AUC no differences | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: High frequency of Nk cells and of NK/CD11b+ cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: No phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: Increased absolute (ANOVA) and normalized heart weight
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: not analysed
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Decreased body mass; reduced body fat and increased lean mass in females | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in stomach, testes, coagulating gland, ovary, uterus | Report |
|
Uhrf1 |
Uhrf1tm1a(EUCOMM)Wtsi
MGI:4434100 | Uhrf1
ubiquitin-like with PHD and ring finger domains 1 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: OF: Increased distance travelled by the male mutants during the 3rd 5 minutes of the test; Decreased PPI in the male mutants | Dysmorphology, Bone and Cartilage Screen
Phenotype:
New phenotype
Phenotype
description: decreased BMC in males; decreased body length, body weight (males) and fat mass (males). | Neurological Screen
Phenotype:
New phenotype
Phenotype
description: Abnormal gait | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Fasted mice: Low non-HDL-cholesterol and triglycerides (mild); Fed mice: Slightly increased ALP activity?? IpGTT: fasting-induced BW loss high, fasted basal glucose level high, AUC increased | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: FACS: Higher frequency of NK cells | Allergy Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Steroid Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: no organs collected
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: Decreased body mass, but increased metabolic rate in females, increased RER, but only in females trend of reduced fat mass | Pathology Screen
Phenotype:
New phenotype
Phenotype
description: Differences in the expression of ß galactosidase activity between mutant and control mice were observed in ependym, aorta, spleen, ovar, skin | Report |
|
Popdc2 |
Popdc2tm1Tbd
MGI:3773727 | Popdc2
popeye domain containing 2 | Behavioral Screen
Phenotype:
New phenotype
Phenotype
description: hypoactivtiy (exhaustion, fatigue?) | Dysmorphology, Bone and Cartilage Screen
Phenotype:
Additional phenotype
Phenotype
description: Changes in bone homeostasis and body composition (males) | Neurological Screen
Phenotype:
Additional phenotype
Phenotype
description: muscle phenotype | Eye Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Clinical Chemical Screen
Phenotype:
New phenotype
Phenotype
description: Micro- and polycytic blood cell count. Indications of changes in bone metabolism, muscle energy metabolism, and balance of electrolytes. | Immunology Screen
Phenotype:
New phenotype
Phenotype
description: Complex phenotype affecting both the cellular subsets distribution and immunoglobulin levels in the periphery | Allergy Screen
Phenotype:
New phenotype
Phenotype
description: lower IgE levels in female mutants | Steroid Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Nociceptive Screen
Phenotype:
No phenotype
Phenotype
description: no phenotype | Cardiovascular Screen
Phenotype:
Not tested
Phenotype
description: not tested
| Lung Function Screen
Phenotype:
No phenotype
Phenotype
description: minor changes | Molecular Phenotyping Screen
Phenotype:
Not tested
Phenotype
description: No organs selected for expression profiling
| Energy Metabolism Screen
Phenotype:
New phenotype
Phenotype
description: reduced body weight, | Pathology Screen
Phenotype:
No phenotype
Phenotype
description: (BW reduced (males)) | Report |